Initial treatment of patients with early rheumatoid arthritis (RA).
| Type of Treatment | n (%) of Patients |
|---|---|
| MTX alone or in combination | 86 (85.1) |
| MTX alone | 30 (29.7) |
| LFN | 10 (9.9) |
| MTX + LFN | 7 (6.9) |
| HCQ | 20 (19.8) |
| CQ | 31 (30.7) |
| MTX + HCQ/CQ | 48 (47.5) |
| SSZ | 25 (24.8) |
| MTX + SSZ | 20 (19.8) |
| AZA | 1 (1) |
| PDN | 61 (60.4) |
| Biologic | 3 (3) |
| MTX combination therapy | 68 (67.3) |
MTX: methotrexate; LFN: leflunomide; HCQ: hydroxychloroquine; CQ: chloroquine; SSZ: sulfasalazine; AZA: azathioprine; PDN: prednisone.